Skip to main navigation Skip to search Skip to main content

12‐month safety and efficacy of everolimus with reduced exposure cyclosporine in de novo renal transplant recipients

  • Helio Tedesco-Silva
  • , Stefan Vitko
  • , Julio Pascual
  • , Josette Eris
  • , John C. Magee
  • , John Whelchel
  • , Giovanni Civati
  • , Scott Campbell
  • , Gentil Alves-Filho
  • , Bernard Bourbigot
  • , Valter Duro Garcia
  • , John Leone
  • , Ronaldo Esmeraldo
  • , Paolo Rigotti
  • , Vincenzo Cambi
  • , Tomas Haas
  • , study groups
  • Division of Nephrology, Hospital do Rim e Hipertensao, Sao Paolo, Brazil
  • Transplant Centre IKEM, Prague, Czech Republic
  • Servicio de Nefrologia, Hospital Ramon y Cajal, Madrid, Spain
  • Royal Prince Alfred Hospital
  • University of Michigan
  • Piedmont Hospital
  • Divisione Nefrologia e Dialisi, Az. Osp. Niguarda Ca’ Granda, Milano, Italy
  • Princess Alexandra Hospital
  • State University of Campinas
  • Service de Nephrologie, CHU, Hôpital Cavale Blanche, Brest, France
  • Santa Casa de Misericóridia de Porto Alegre, RS, Brazil
  • Tampa General Hospital
  • Hospital Geral de Fortaleza – Setor de Transplante Renal, Fortaleza, Ceará, Brazil
  • Department of Medical and Surgical Sciences, Policlinico Hospital, Padua, Italy
  • Department of Medicine and Nephrology, Maggiore Hospital, Parma, Italy
  • Novartis

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalTransplant International
Volume20
Issue number1
DOIs
StatePublished - Jan 1 2007
Externally publishedYes

Disciplines

  • Pharmacology
  • Medicine and Health Sciences
  • Urology

Cite this